Posted on 1/15/19
AXIM Biotechnologies Launches New Website and Management Presentation
NEW YORK, Jan. 15, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today . . .
Posted on 1/15/19
Cisive Announces Strategic Combination with PreCheck
HOLTSVILLE, N.Y.--(BUSINESS WIRE)--Cisive, a global provider of compliance-driven human capital management and risk management solutions, announces the acquisition of PreCheck, the healthcare industry’s leading provider of . . .
Posted on 1/15/19
Bioharmony Therapeutics and Boehringer Ingelheim Collaborate
NEW YORK--(BUSINESS WIRE)--Bioharmony Therapeutics, Inc., a biopharmaceutical company focusing on the development of novel therapeutics for hard to treat bacterial infections, announced today that it has . . .
Posted on 1/15/19
QPharma Welcomes New Clients, Celebrates 25-Year Anniversary
MORRISTOWN, N.J.--(BUSINESS WIRE)--QPharma, a premier provider of commercial and compliance services to the life sciences industry, has announced that the company will mark its 25th year . . .
Posted on 1/15/19
Here's How Pfizer Gained 20.5% in 2018
What happenedShares of Pfizer (NYSE:PFE) gained 20.5% in 2018, according to data from S&P Global Market Intelligence, while its industry was getting hammered. The iShares U.S. . . .
Posted on 1/15/19
ORHub Announces New Contract with Metropolitan Surgery Center in New Jersey
ORHub, Inc. (OTC: ORHB), a SaaS-based healthcare data analytics company focused on the business of surgery to improve the profitability of hospitals, ambulatory surgery centers (ASCs) . . .
Posted on 1/15/19
RogCon and Prometheus Research Enter into Partnership
RogCon Biosciences, Inc., (RogCon), a biotechnology company leading the discovery and development of novel treatments for patients suffering from SCN2A (Nav1.2) mutations, has partnered with Prometheus . . .
Posted on 1/15/19
Cancer Genetics Closes Public Offering of Common Stock
RUTHERFORD, N.J., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular . . .
Posted on 1/15/19
Stemline Therapeutics Announces Proposed Public Offering of Common Stock
NEW YORK, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative oncology therapeutics, . . .
Posted on 1/14/19
Empire BlueCross and Empire BlueCross BlueShield Collaborate With CVS Pharmacy
ALBANY, N.Y.--(BUSINESS WIRE)--Empire BlueCross and Empire BlueCross BlueShield (Empire) announced today that, beginning January 2019, consumers enrolled in its Medicare Advantage health plans will be able . . .
Posted on 1/14/19
Local Measure Partners With Snap to Offer Brands’ Snap
SYDNEY & NEW YORK--(BUSINESS WIRE)--Local Measure, a customer experience platform that provides customer insights for retail, hospitality, tourism, sports and entertainment industries, announced an integration with . . .
Posted on 1/14/19
Amerigroup Collaborates with CVS Pharmacy
ISELIN, N.J.--(BUSINESS WIRE)--Amerigroup in New Jersey announced today that, beginning January 2019, consumers enrolled in its Medicare Advantage health plans will be able to purchase over-the-counter . . .
Posted on 1/14/19
Better Buy: Baker Hughes vs. Core Laboratories
It has been challenging to grow your wealth investing in oil stocks over the past few years. Even though Baker Hughes, a GE Company (NYSE:BHGE) and . . .
Posted on 1/14/19
Why Teladoc Health Stock Fell 20.6% in December
What happenedTeladoc Health (NYSE:TDOC) lost more than 20% of its value last month, according to data provided by S&P Global Market Intelligence, amid allegations of wrongdoing . . .
Posted on 1/14/19
Bristol-Myers: Fattening Up The Pipeline With Celgene
SummaryBristol-Myers' $74bn deal for Celgene should be a net positive.Deal creates the #1 oncology franchise.Management is guiding to some lofty post-deal, synergy targets.We think BMY is . . .
Posted on 1/14/19
Here's Why Merck & Co. Surged 35.8% in 2018
What happenedShares of Merck & Co. (NYSE:MRK), a big pharmaceutical company, climbed 35.8% in 2018, according to data from S&P Global Market Intelligence. Continued success with . . .
Posted on 1/11/19
Cancer Genetics Prices Public Offering of Common Stock
RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular . . .
Posted on 1/10/19
Why Johnson & Johnson Stock Fell 12% in December
What happenedJohnson & Johnson (NYSE:JNJ) shares trailed the market last month as the stock lost 12% compared to a 9% slump in the S&P 500, according . . .
Posted on 1/9/19
BioHiTech and Sprouts Partner
BioHiTech Global, Inc. (NASDAQ: BHTG), a technology and services company that provides cost-effective and sustainable waste management solutions, today announced the installation of BioHiTech Revolution Series Digester . . .
Posted on 1/9/19
FierceHealthcare Awards Hoy Health as one of its 2019 “Fierce 15” Companies, Recognizing its Innovative Healthcare Solutions
MORRISTOWN, N.J.--(BUSINESS WIRE)--Hoy Health, LLC announces that it has been named by FierceHealthcare as one of the 2019 Fierce 15 companies, designating it as one of . . .
Posted on 1/9/19
Rectangle Health Selects Boomtown to Strengthen Customer Experience
Boomtown, the leading provider of technology support software and services, today announced that New York-based Rectangle Health, a leading provider of healthcare payment processing for more . . .
Posted on 1/9/19
3 Things Bristol-Myers Squibb Understands About Celgene That the Market Hasn't
Healthcare's biggest event of the year is now under way -- the J.P. Morgan Healthcare Conference. Over the past several years, Celgene (NASDAQ:CELG) has traditionally kicked . . .
Posted on 1/8/19
Johnson & Johnson Innovation to Join NXT Biomedical Therapeutic Device Incubator to Accelerate Medical Device Innovation
Johnson & Johnson Innovation, LLC today announced it entered a definitive agreement to join NXT Biomedical Therapeutic Device Incubator through a strategic investment facilitated by Johnson . . .
Posted on 1/8/19
Axsome Therapeutics: Still 5 Catalysts Ahead In 2019
SummaryAxsome Therapeutics has a rich pipeline of drugs.ADVANCE-1 is AXSM's trial of AXS-05 in Alzheimer's disease-related agitation.An interim analysis of ADVANCE-1 recently passed which I believe . . .
Posted on 1/8/19
Merck & Co., Inc. (MRK) at JPMorgan Healthcare Conference (Transcript)
Earning Call AudioStart Time: 19:30 January 1, 0000 7:55 PM ETMerck & Co., Inc. (NYSE:MRK)JPMorgan Healthcare ConferenceJanuary 07, 2019, 19:30 PM ETCompany ParticipantsKen Frazier - Chairman . . .

